Curus strengthens the team and continues its focus on digital health investments with the recruitment of Erik Olsson as new Investment Manager. Erik joins Curus from SEB Corporate Finance where he worked on M&A and ECM transactions in the Nordics.

Johan Bloom, CEO at Curus comments:

– I am very proud that we have been able to recruit Erik to join us at Curus. Erik complements me well with solid transactional experience from M&A as well as capital raising for large and mid-sized companies in the Nordic region. With Erik’s experience from corporate finance and my experience and network in e-health, we have a very good team to accelerate investments, acquisitions and building companies in this fast-growing industry. I am excited to start working with Erik and continue to build on Curus’ vision.

Recently, Alfvén & Didrikson, Stefan Bengtsson and Alex Stendahl invested SEK 136 million in Curus to take a dominant position in digital health in the Nordics. Today, Curus has 22 holdings in growth companies such as Mindler, Doctrin, Colivia, FindOut Diagnostic, Knodd, Health Integrator and others, as well as two wholly owned subsidiaries in Add Health Media and newly acquired Pharma Industry Publishing.

– I’m very excited to join Curus and accelerate Curus’ digital health efforts. It’s exciting to switch side of the table while also having the opportunity to continue supporting companies and entrepreneurs in their growth ambitions. We are facing an exciting time with macro factors that opens up for great opportunities to grow Curus through new acquisitions and at the same time support our portfolio companies in the fast-moving digital landscape within healthcare, says Erik Olsson, Investment Manager at Curus.

Erik holds a Master of Business Administration from Lund University, and in addition to experience from SEB Corporate Finance, he also has experience from Swedbank Corporate Finance and HDR Partners.

For more information:
Johan Bloom, VD Curus
[email protected], +46 733 64 84 90

Erik Olsson, Investment Manager
[email protected], +46 708 37 73 54